BIOSECURE Act Update Offers Biotech Companies Eight Years to Divest Contracts With Firms Of ‘Concern’

 
• By Derrick Gingery
USA v China
The BIOSECURE Act update follows what a pharma trade group said was the time needed to fully decouple from biotech companies of concern. • Source: Shutterstock

More from China

More from Asia